The presence and longevity of peripherally expanded donor-derived TCRαβ+ mature T lymphocyte clones after allogeneic bone marrow transplantation for adult myeloid leukemias

Leukemia

Volumn 17, Issue 8, 2003, Pages 1626-1635

  Saitoh, H ^a   Hirokawa, M ^a   Fujishima, N ^a   Ichikawa, Y ^a   Kawabata, Y ^a   Miura, I ^a   Miura, A B ^a   Matsutani, T ^b   Suzuki, R ^b   Sawada, K ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHIONOGI AND CO LTD   (Japan)

Author keywords

Allogeneic bone marrow transplantation; Peripheral expansion; TCR + T lymphocytes

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; GANCICLOVIR; METHOTREXATE;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; AMINO ACID SEQUENCE; ARTICLE; BLOOD DONOR; CELL CLONING; CELL MATURATION; CELL REGENERATION; CIRCULATION; CONTROLLED STUDY; DONOR; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOMEOSTASIS; HUMAN; LONGEVITY; LYMPHOCYTE DIFFERENTIATION; MYELOID LEUKEMIA; PRIORITY JOURNAL; RECIPIENT; STEM CELL; T LYMPHOCYTE;

EID: 0042026859     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402994     Document Type: Article

References (48)

1. Mackall CL, Hakim FT, Gress RE. T-cell regeneration: all repertoires are not created equal. Immunol Today 1997; 18: 245-251.
2. Mackall CL, Gress RE. Thymic aging and T-cell regeneration. Immunol Rev 1997; 160: 91-102.
3. Matsutani T, Yoshioka T, Tsuruta Y, Iwagami S, Toyosaki-Maeda T, Horiuchi T et al. Restricted usage of T-cell receptor α-chain variable region (TCRAV) and T-cell receptor β-chain variable region (TCRBV) repertoires after human allogeneic haematopoietic transplantation. Br J Haematol 2000; 109: 759-769.
4. Hirokawa M, Horiuchi T, Kitabayashi A, Kawabata Y, Matsutani T, Suzuki R et al. Delayed recovery of CDR3 complexity of the T cell receptor β chain in recipients of allogeneic bone marrow transplants who had virus-associated interstitial pneumonia: monitor of T-cell function by CDR3 spectratyping. J Allergy Clin Immunol 2000; 106: 32-39.
5. Horiuchi T, Hirokawa M, Kawabata Y, Kitabayashi A, Matsutani T, Yoshioka T et al. Identification of the T-cell clones expanding within both CD8+CD28+ and CD8+CD28- T-cell subsets in recipients of allogeneic hematopoietic cell grafts and its implication in post-transplant skewing of T-cell receptor repertoire. Bone Marrow Transplant 2001; 27: 731-739.
6. Hirokawa M, Matsutani T, Horiuchi T, Kawabata Y, Kitabayashi A, Yoshioka T et al. Extensive clonal expansion of T lymphocytes causes contracted diversity of the complementarity-determining region 3 and a skewing of T-cell receptor repertoires after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2001; 27: 607-614.
7. Mackall CL, Bare CV, Granger LA, Sharrow SO, Titus JA, Gress RE. Thymic-independent T cell regeneration occurs via antigen-driven expansion of peripheral T cells resulting in a repertoire that is limited in diversity and prone to skewing. J Immunol 1996; 156: 4609-4616.
8. Hirokawa M, Horiuchi T, Kawabata Y, Kitabayashi A, Miura AB. Reconstitution of γδ T-cell repertoire diversity after human allogeneic hematopoietic cell transplantation and the role for peripheral expansion of mature T-cell population in the graft. Bone Marrow Transplant 2000; 26: 177-185.
9. Storb R, Deeg HJ, Whitehead J, Appelbaum F, Beatty P, Bensinger W et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft-versus-host disease after marrow transplantation for leukemias. N Engl J Med 1986; 314: 729-735.
10. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974; 18: 295-304.
11. Boeckh M, Bowden RA, Goodrich JM, Pettinger M, Meyers JD. Cytomegalovirus antigen detection in peripheral blood leukocytes after allogeneic marrow transplantation. Blood 1992; 80: 1358-1364.
12. Yau JC, Dimopoulos MA, Huan SD, Tarrand JJ, Spencer V, Spitzer G et al. Prophylaxis of cytomegalovirus infection with ganciclovir in allogeneic marrow transplantation. Eur J Haematol 1991; 47: 371-376.
13. Pannetier C, Cochet M, Darche S, Casrouge A, Zoller M, Kourilsky P. The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments. Proc Natl Acad Sci USA 1993; 90: 4319-4323.
14. Kitabayashi A, Hirokawa M, Hatano Y, Lee M, Kuroki J, Niitsu H et al. Granulocyte colony-stimulating factor down-regulates allogeneic immune responses by post-transcriptional inhibition of tumor necrosis factor-α production. Blood 1995; 86: 2220-2227.
15. Kawabata Y, Hirokawa M, Kitabayashi A, Horiuchi T, Kuroki J, Miura AB. Defective apoptotic signal transduction pathway downstream of caspase-3 in human B-lymphoma cells: a novel mechanism of nuclear apoptosis resistance. Blood 1999; 94: 3523-3530.
16. Yoshioka T, Matsutani T, Iwagami S, Tsuruta Y, Kaneshige T, Toyosaki T et al. Quantitative analysis of the usage of human T cell receptor alpha and beta chain variable regions by reverse dot blot hybridization. J Immunol Methods 1997; 201: 145-155.
17. Matsutani T, Yoshioka T, Tsuruta Y, Iwagami S, Suzuki R. Analysis of TVRAV and TCRBV repertoires in healthy individuals by microplate hybridization assay. Hum Immunol 1997; 56: 57-69.
18. Yoshioka T, Matsutani T, Iwagami S, Toyosaki-Maeda T, Yutsudo T, Tsuruta Y et al. Polyclonal expansion of TCRBV2 and TCRBV6-bearing T cells in patients with Kawasaki disease. Immunology 1999; 96: 465-472.
19. Tsuruta Y, Iwagami S, Furue S, Teraoka H, Yoshida T, Sakata T et al. Detection of human T cell receptor cDNAs (α, β, γ and δ) by ligation of a universal adaptor to variable region. J Immunol Methods 1993; 161: 7-12.
20. Posnett DN, Sinha R, Kabak S, Russo C. Clonal populations of T cells in normal elderly humans: the T cell equivalent to 'benign monoclonal gammapathy'. J Exp Med 1994; 179: 609-618.
21. Schwab R, Szabo P, Manavalan JS, Weksler ME, Posnett DN, Pannetier C et al. Expanded CD4+ and CD8+ T cell clones in elderly humans. J Immunol 1997; 158: 4493-4499.
22. Khan N, Shariff N, Cobbold M, Bruton R, Ainsworth JA, Sinclair AJ et al. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J Immunol 2002; 169: 1984-1992.
23. Kronenberg M, Siu G, Hood LE, Shastri N. The molecular genetics of the T-cell antigen receptor and T-cell antigen recognition. Annu Rev Immunol 1986; 4: 529-591.
24. a-encoded antigens. Nature 1988; 332: 40-45.
25. Kappler JW, Roehm N, Marrack P. T cell tolerance by clonal elimination in the thymus. Cell 1987; 49: 273-280.
26. Teh HS, Kisielow P, Scott B, Kishi H, Uematsu Y, Bluthmann H et al. Thymic major histocompatibility antigens and the α-β T cell receptor determine the CD4/CD8 phenotype of T cells. Nature 1988; 335: 229-233.
27. Sha WC, Nelson CA, Newberry RD, Kranz DM, Russell JH, Loh DY. Positive and negative selection of an antigen receptor on T cells in transgenic mice. Nature 1988; 336: 73-76.
28. Tayebi H, Tiberghien P, Ferrand C, Lienard A, Duperrier A, Cahn JY et al. Allogeneic peripheral blood stem cell transplantation results in less alteration of early T cell compartment homeostasis than bone marrow transplantation. Bone Marrow Transplant 2001; 27: 167-175.
29. Patel DD, Gooding ME, Parrott RE, Curtis KM, Haynes BF, Buckley RH. Thymic function after hematopoietic stem-ceil transplantation for the treatment of severe combined immunodeficiency. N Engl J Med 2000; 342: 1325-1332.
30. Hazenberg MD, Otto SA, de Pauw ES, Roelofs H, Fibbe WE, Hamann D et al. T-cell receptor excision circle and T-cell dynamics after allogeneic stem cell transplantation are related to clinical events. Blood 2002; 99: 3449-3353.
31. Marmont AM, Horowitz MM, Gale RP, Sobocinski K, Ash RC, van Bekkum DW et al. T-cell depletion of HLA-identical transplants in leukemia. Blood 1991; 78: 2120-2130.
32. Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990; 75: 555-562.
33. Bacigalupo A, Soracco M, Vassallo F, Abate M, Van Lint MT, Gualandi F et al. Donor lymphocyte infusions (DLI) in patients with chronic myeloid leukemia following allogeneic bone marrow transplantation. Bone Marrow Transplant 1997; 19: 927-932.
34. Collins Jr RH, Shpilberg O, Drobyski WR, Porter DL, Giralt S, Champlin R et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol 1997; 15: 433-444.
35. Eder M, Battmer K, Kafert S, Stucki A, Ganser A, Hertenstein B. Monitoring of BCR-ABL expression using real-time RT-PCR in CML after bone marrow or peripheral blood stem cell transplantation. Leukemia 1999; 13: 1383-1389.
36. Khouri IF, Keating M, Korbling M, Przepiorka D, Anderlini P, O'Brien S et al. Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies. J Clin Oncol 1998; 16: 2817-2824.
37. Badros A, Barlogie B, Siegel E, Cottler-Fox M, Zangari M, Fassas A et al. Improved outcome of allogeneic transplantation in high-risk multiple myeloma patients after nonmyeloablative conditioning. J Clin Oncol 2002; 20: 1295-1303.
38. Miyamura K, Barrett AJ, Kodera Y, Saito H. Minimal residual disease after bone marrow transplantation for chronic myelogenous leukemia and implications for graft-versus-leukemia effect: a review of recent results. Bone Marrow Transplant 1994; 14: 201-209.
39. Claret EJ, Alyea EP, Orsini E, Pickett CC, Collins H, Wang Y et al. Characterization of T cell repertoire in patients with graft-versus-leukemia after donor lymphocyte infusion. J Clin Invest 1997; 15: 100: 855-866.
40. Hirokawa M, Matsutani T, Saitoh H, Ichikawa Y, Kawabata Y, Horiuchi T et al. Distinct TCRAV and TCRBV repertoire and CDR3 sequence of T lymphocytes clonally expanded in blood and GVHD lesions after human allogeneic bone marrow transplantation. Bone Marrow Transplant 2002; 30: 915-923.
41. Kern F, Bunde T, Faulhaber N, Kiecker F, Khatamzas E, Rudawski IM et al. Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals. J Infect Dis 2002; 185: 1709-1716.
42. Aubert G, Hassan-Walker AF, Madrigal JA, Emery VC, Morte C, Grace S et al. Cytomegalovirus-specific cellular immune responses and viremia in recipients of allogeneic stem cell transplants. J Infect Dis 200; 184: 955-963.
43. Ozdemir E, St John LS, Gillespie G, Rowland-Jones S, Champlin RE, Molldrem JJ et al. Cytomegalovirus reactivation following allogeneic stem cell transplantation is associated with the presence of dysfunctional antigen-specific CD8+ T cells. Blood 2002; 100: 3690-3697.
44. Benz C, Utermohlen O, Wulf A, Villmow B, Dries V, Goeser T et al. Activated virus-specific T cells are early indicators of anti-CMV immune reactions in liver transplant patients. Gastroenterology 2002; 122: 1201-1215.
45. Gratama JW, van Esser JW, Lamers CH, Tournay C, Lowenberg B, Bolhuis RL et al. Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection. Blood 2001; 98: 1358-1364.
46. Hassan-Walker AF, Vargas Cuero AL, Mattes FM, Klenerman P, Lechner F, Burroughs AK et al. CD8+ cytotoxic lymphocyte responses against cytomegalovirus after liver transplantation: correlation with time from transplant to receipt of tacrolimus. J Infect Dis 2001; 183: 835-843.
47. Singhal S, Shaw JC, Ainsworth J, Hathaway M, Gillespie GM, Paris H et al. Direct visualization and quantitation of cytomegalovirus-specific CD8+ cytotoxic T-lymphocytes in liver transplant patients. Transplantation 2000; 69: 2251-2259.
48. Concannon P, Robinson MA. Human T-cell receptor gene nomenclature. Ann NY Acad Sci 1995; 756: 124-129.